Condition
Alzheimer Disease 3
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Unknown2
Withdrawn1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05637801Not ApplicableActive Not Recruiting
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
NCT04100889Withdrawn
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
NCT05969054Phase 4UnknownPrimary
Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy
NCT03806478Phase 2Unknown
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
Showing all 4 trials